COVID-19's impact on primary care and related mitigation strategies: A scoping review.

Infectious diseases general general practice/family medicine health care organisation and management public health and community medicine

Journal

The European journal of general practice
ISSN: 1751-1402
Titre abrégé: Eur J Gen Pract
Pays: England
ID NLM: 9513566

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 20 7 2021
pubmed: 21 7 2021
medline: 28 7 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has had a substantial impact on primary care throughout Europe and globally. This review aims to ascertain how the pandemic has impacted primary care service provision/patients and to examine strategies to mitigate these impacts. The scoping review framework comprised a six-stage process developed by Arksey and O'Malley. The search process was guided by the Joanna Briggs Institute three-step search strategy and involved searching the PubMed, Embase, Scopus, CINAHL Plus, and Cochrane Library databases. The review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. A thematic analysis approach by Braun and Clarke was used to interpret the findings. Thirty-two studies from 18 countries and six continents were included, 13 reported original research, three were reviews, and 16 were case reports reporting healthcare systems' experiences of dealing with the pandemic. Emerging themes concerned the COVID-19 pandemic's impact on primary care service provision and patients, the impact of the rapid transition to telemedicine due to COVID-19 on primary care, and strategies to mitigate the impact of COVID-19 on primary care (i.e. infection prevention and control measures, alternatives/modifications to traditional service delivery or workflow, government policy responses, and education). The COVID-19 pandemic has considerably impacted on primary care at both service and patient levels, and various strategies to mitigate these impacts have been described. Future research examining the pandemic's ongoing impacts on primary care, as well as strategies to mitigate these impacts, is a priority.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic has had a substantial impact on primary care throughout Europe and globally.
OBJECTIVES OBJECTIVE
This review aims to ascertain how the pandemic has impacted primary care service provision/patients and to examine strategies to mitigate these impacts.
METHODS METHODS
The scoping review framework comprised a six-stage process developed by Arksey and O'Malley. The search process was guided by the Joanna Briggs Institute three-step search strategy and involved searching the PubMed, Embase, Scopus, CINAHL Plus, and Cochrane Library databases. The review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. A thematic analysis approach by Braun and Clarke was used to interpret the findings.
RESULTS RESULTS
Thirty-two studies from 18 countries and six continents were included, 13 reported original research, three were reviews, and 16 were case reports reporting healthcare systems' experiences of dealing with the pandemic. Emerging themes concerned the COVID-19 pandemic's impact on primary care service provision and patients, the impact of the rapid transition to telemedicine due to COVID-19 on primary care, and strategies to mitigate the impact of COVID-19 on primary care (i.e. infection prevention and control measures, alternatives/modifications to traditional service delivery or workflow, government policy responses, and education).
CONCLUSION CONCLUSIONS
The COVID-19 pandemic has considerably impacted on primary care at both service and patient levels, and various strategies to mitigate these impacts have been described. Future research examining the pandemic's ongoing impacts on primary care, as well as strategies to mitigate these impacts, is a priority.

Identifiants

pubmed: 34282695
doi: 10.1080/13814788.2021.1946681
pmc: PMC8293960
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-175

Références

J Gen Intern Med. 2020 Oct;35(10):3073-3076
pubmed: 32705471
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):833-838
pubmed: 32540738
Am J Hosp Palliat Care. 2020 Nov;37(11):985-987
pubmed: 32720520
J Clin Epidemiol. 2014 Dec;67(12):1291-4
pubmed: 25034198
Maturitas. 2020 Dec;142:8-10
pubmed: 33158491
Healthc (Amst). 2020 Sep;8(3):100454
pubmed: 32919584
J Rehabil Med. 2020 May 25;52(5):jrm00063
pubmed: 32449782
Am J Phys Med Rehabil. 2020 Jun;99(6):470-474
pubmed: 32282359
J Med Internet Res. 2020 Jun 29;22(6):e19786
pubmed: 32540845
Hong Kong Med J. 2020 Jun;26(3):176-183
pubmed: 32475841
Int Nurs Rev. 2020 Sep;67(3):326-333
pubmed: 32567057
Afr J Prim Health Care Fam Med. 2020 Jun 04;12(1):e1-e4
pubmed: 32501022
Afr J Prim Health Care Fam Med. 2020 Jun 18;12(1):e1-e3
pubmed: 32634004
Ann Intern Med. 2020 Oct 6;173(7):527-535
pubmed: 32628536
R I Med J (2013). 2020 Apr 1;103(3):9-10
pubmed: 32236152
Diabetes Res Clin Pract. 2020 Jul;165:108246
pubmed: 32502693
Am J Nurs. 2014 May;114(5):49-56
pubmed: 24759479
Stud Health Technol Inform. 2020 Jun 26;272:9-12
pubmed: 32604587
Res Social Adm Pharm. 2021 Jan;17(1):2002-2004
pubmed: 33317768
Lancet Oncol. 2020 May;21(5):633
pubmed: 32325021
Prim Care Diabetes. 2021 Feb;15(1):16-17
pubmed: 32535088
Ann Fam Med. 2020 Jul;18(4):349-354
pubmed: 32661037
JMIR Public Health Surveill. 2020 Jun 25;6(2):e19045
pubmed: 32479413
BMJ Open. 2020 Jun 17;10(6):e039674
pubmed: 32554730
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1439-1443
pubmed: 32755848
Harm Reduct J. 2020 Jul 17;17(1):49
pubmed: 32680520
Int J Infect Dis. 2020 May;94:128-132
pubmed: 32251805
Am J Public Health. 2012 Dec;102(12):e24-32
pubmed: 23078479
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
Afr J Prim Health Care Fam Med. 2020 Jun 03;12(1):e1-e3
pubmed: 32501021
Codas. 2020 Jun 22;32(3):e20200144
pubmed: 32578694
J Am Med Inform Assoc. 2020 Jun 1;27(6):860-866
pubmed: 32267928
BMC Public Health. 2016 May 17;16:410
pubmed: 27185252
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Ann Fam Med. 2020 May;18(3):259-261
pubmed: 32393562
Appl Clin Inform. 2020 Mar;11(2):265-275
pubmed: 32268390
Int J Clin Pract. 2020 Oct;74(10):e13592
pubmed: 32563197
Telemed J E Health. 2021 Jan;27(1):107-112
pubmed: 32614689
Int J Antimicrob Agents. 2020 Jun;55(6):105948
pubmed: 32201353
Br J Gen Pract. 2020 Jul 30;70(697):e540-e547
pubmed: 32661009
J Am Med Dir Assoc. 2020 Jul;21(7):951-953
pubmed: 32674826
Lancet Oncol. 2020 Jun;21(6):748-750
pubmed: 32359404
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
West J Emerg Med. 2020 Jan 31;21(2):184-190
pubmed: 32191174
J Adolesc Health. 2020 Aug;67(2):290-295
pubmed: 32527573
BMJ. 2020 Mar 18;368:m1090
pubmed: 32188598
J Gen Intern Med. 2020 Oct;35(10):3077-3080
pubmed: 32720239

Auteurs

Jayleigh Lim (J)

School of Medicine, University College Dublin, Dublin, Ireland.

John Broughan (J)

School of Medicine, University College Dublin, Dublin, Ireland.

Des Crowley (D)

School of Medicine, University College Dublin, Dublin, Ireland.
Health Services, Addiction Services, Dublin, Ireland.

Brendan O'Kelly (B)

School of Medicine, University College Dublin, Dublin, Ireland.
Mater Misericordiae University Hospital, Dublin, Ireland.

Ronan Fawsitt (R)

School of Medicine, University College Dublin, Dublin, Ireland.
Castle Gardens Surgery, Kilkenny, Ireland.
Ireland East Hospital Group, Dublin, Ireland.

Mary Carmel Burke (MC)

Mater Misericordiae University Hospital, Dublin, Ireland.
Glasnevin Family Practice, Dublin, Ireland.

Geoff McCombe (G)

School of Medicine, University College Dublin, Dublin, Ireland.

John S Lambert (JS)

School of Medicine, University College Dublin, Dublin, Ireland.
Mater Misericordiae University Hospital, Dublin, Ireland.

Walter Cullen (W)

School of Medicine, University College Dublin, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH